EN
HI
Summary
As of 4 Oct, 2026, Alembic Pharmaceuticals stock price is ₹815.25. During the trading session, the stock has moved between an intraday low of ₹803.50 and an intraday high of ₹827.85. Over the last 52 weeks, Alembic Pharmaceuticals has traded between ₹635.80 and ₹998.00.
The stock has recorded a trading volume of 3,27,528 shares,. Its Average Traded Price (ATP) is ₹815.10, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹815.25.
Alembic Pharmaceuticals has an upper circuit limit of ₹978.30 and a lower circuit limit of ₹652.20. The total value traded stands at ₹26.70 CR, and the delivery percentage for the day is 51.02%.
The stock is currently traded with a market lot size of 1. Alembic Pharmaceuticals also offers a dividend yield of 1.47%.
Alembic Pharmaceuticals Share Price Chart
Alembic Pharmaceuticals Share Key Metrics
Volume
3.28 L
Market Cap
16024.81 CR
LTQ@LTP
5@815.25
ATP
815.1
Var Margin
15.35 %
Circuit Range
652.2-978.3
Delivery %
51.02 %
Value
26.70 CR
ASM/GSM
No
Market Lot
1
Alembic Pharmaceuticals Fundamentals
P/E Ratio
23.1
P/B Ratio
2.74
Div. Yield
1.47
Sector P/E
42.73
Sector P/B
3.55
Sec. Div. Yield
0.52
Alembic Pharmaceuticals Resistance and Support
Pivot 841.18
Resistance
First Resistance
860.66
Second Resistance
895.88
Third Resistance
915.36
Support
First Support
805.96
Second Support
786.48
Third Support
751.26
Alembic Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 01 2026 | 816 | 815.25 | -1.24% | 827.85 | 803.5 |
| Wed Sep 30 2026 | 866 | 825.45 | -4.18% | 876.4 | 821.7 |
| Tue Sep 29 2026 | 853.9 | 861.5 | 0.84% | 868 | 837.5 |
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-04 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
| 2024-11-07 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Update On USFDA Inspection Conducted During 3Rd March, 2025 To 7Th March, 2025 At Bioequivalence Facility Located At Vadodara, Gujarat.
Alembic Pharmaceuticals received the Establishment Inspection Report (EIR) from the USFDA for its Bioequivalence Facility in Vadodara, Gujarat. The USFDA has also communicated the closure of the inspection, which was carried out from 3rd March to 7th March 2025.
Sep 16 2026 18:07:08
Alembic Pharmaceuticals Ltd - 533573 - Intimation Regarding Successful Completion Of Unannounced USFDA Onsite Bioequivalence Inspection.
Alembic Pharma successfully completed an unannounced USFDA inspection at its Bioequivalence Facility in Vadodara, Gujarat. The inspection concluded with no Form 483 observations, indicating compliance with regulatory standards.
Sep 11 2026 11:37:41
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Shilpa Medicare Ltd.
1064.10
16.90 (1.61%)
Astrazeneca Pharma India Ltd.
6031.00
-155.00 (2.51%)
Onesource Specialty Pharma Ltd.
1508.00
-13.60 (0.89%)
Pfizer Ltd.
3858.90
-16.40 (0.42%)
Cohance Lifesciences Ltd.
451.30
7.30 (1.64%)
Eris Lifesciences Ltd.
1189.80
-2.10 (0.18%)
Jubilant Pharmova Ltd.
999.30
-29.50 (2.87%)
Poly Medicure Ltd.
1638.10
-35.70 (2.13%)
Dr. Agarwal's Health Care Ltd.
486.45
7.15 (1.49%)
Marksans Pharma Ltd.
325.60
3.30 (1.02%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 815.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 23.1. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.74. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 42.73 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 16024.81 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 998.00 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in APLLTD
